Table 2 Dose, duration, and response to... | American Society of Hematology

Table 2

Dose, duration, and response to imatinib and the results of the recent follow-up

Pt	Imatinib dose	Response to imatinib	Duration of therapy, mo	Current status	Most recent WBC, × 10⁹/L	Most recent Eos, × 10⁹/L	Most recent Plts, × 10⁹/L	Most recent cytogenetics and/or FISH (mo after imatinib start)	Duration of survival since diagnosis, mo
1	400	Yes	60	Alive	5.6	0.2	224	Normal (24)	75
2	300	Yes	55	Alive	5.8	0.1	235	Normal (24)	73
3	400	Yes	55	Alive	4.6	0.28	166	Normal (51)	109
4	400	Yes	48	Alive	9.4	0.09	303	Normal (39)	57
5	400	Yes	46	Alive	5.7	0.6	232	Normal (12)	55
6	400	Yes	46	Alive	4.6	0.3	150	Normal (41)	47
7	400	Yes	33	Alive	4.9	0.08	231	Normal (24)	34
8	400	Yes	19	Alive	4.3	0.29	196	Normal (16)	36
9	800	Yes	60	Alive	5.5	0.6	324	Normal (60)	234
10	200	Yes	50	Alive	6.3	0.1	296	Normal (30)	75
11	400	Yes; PR	8	Dead	NA	NA	NA	NA	25 (dead)
12	400	Yes*	0.1	Dead	NA	NA	NA	NA	91 (dead)

Pt	Imatinib dose	Response to imatinib	Duration of therapy, mo	Current status	Most recent WBC, × 10⁹/L	Most recent Eos, × 10⁹/L	Most recent Plts, × 10⁹/L	Most recent cytogenetics and/or FISH (mo after imatinib start)	Duration of survival since diagnosis, mo
1	400	Yes	60	Alive	5.6	0.2	224	Normal (24)	75
2	300	Yes	55	Alive	5.8	0.1	235	Normal (24)	73
3	400	Yes	55	Alive	4.6	0.28	166	Normal (51)	109
4	400	Yes	48	Alive	9.4	0.09	303	Normal (39)	57
5	400	Yes	46	Alive	5.7	0.6	232	Normal (12)	55
6	400	Yes	46	Alive	4.6	0.3	150	Normal (41)	47
7	400	Yes	33	Alive	4.9	0.08	231	Normal (24)	34
8	400	Yes	19	Alive	4.3	0.29	196	Normal (16)	36
9	800	Yes	60	Alive	5.5	0.6	324	Normal (60)	234
10	200	Yes	50	Alive	6.3	0.1	296	Normal (30)	75
11	400	Yes; PR	8	Dead	NA	NA	NA	NA	25 (dead)
12	400	Yes*	0.1	Dead	NA	NA	NA	NA	91 (dead)

FISH indicates fluorescence in situ hybridization; NA, not applicable.

Disease response without recovery of peripheral-blood counts; see the fourth paragraph of “Results and discussion.”